Source comparison
Stacking Sermorelin Ipamorelin vs Monotherapy: Comparative Analysis
Mean IGF-1 Increase (ng/mL) +42 +38 +78 Stacking produces 85% greater IGF-1 elevation than either monotherapy GH Pulse Amplitude (μg/L) 12.4 10.8 24.1 Dual-pathway activation nearly doubles peak GH secretion per pulse GH Pulse Duration (min) 95 110 140 Ipamore
This comparison does not assign a generated winner or score.
- Mean IGF-1 Increase (ng/mL)
- +42
- +38
- +78
- Stacking produces 85% greater IGF-1 elevation than either monotherapy
- GH Pulse Amplitude (μg/L)
- 12.4
- 10.8
- 24.1
- Dual-pathway activation nearly doubles peak GH secretion per pulse
- GH Pulse Duration (min)
- 95
- 110
- 140
- Ipamorelin's somatostatin suppression extends the pulse window
- Lean Mass Gain (kg, 12 weeks)
- +1.2
- +0.9
- +2.1
- Synergistic anabolic effect consistent with higher sustained IGF-1
- Injection Site Reactions (%)
- 8%
- 5%
- 11%
- Marginal increase in local irritation with dual injection
- Professional Assessment
- Moderate GH elevation; limited by somatostatin feedback
- Effective GH pulse but lacks primary GHRH signal strength
- Gold standard for physiological GH restoration without exogenous hormone